Medidata Solutions (MDSO) Tops Q4 EPS by 3c

Go back to Medidata Solutions (MDSO) Tops Q4 EPS by 3c

Needham & Company Remains Bullish on Medidata Solutions (MDSO) Despite Revenue Shortfall

February 11, 2016 8:35 AM EST

Needham & Company maintained a Buy rating on Medidata Solutions (NASDAQ: MDSO), and cut the price target to $45.00 (from $65.00), following the company's 4Q earnings report. Despite MDSO's reported revenue shortfall (missed Street estimates by $6MM), Needham would characterize leading indicators as somewhat encouraging. Needham analysts... More

Medidata Solutions (MDSO) PT Lowered to $35 at Jefferies

February 11, 2016 8:20 AM EST

Jefferies analyst David Windley reiterated a Hold rating and lowered his price target on Medidata Solutions (NASDAQ: MDSO) to $35.00 (from $42.00) following Q4 results.

Windley commented, "Our LT concerns remain regarding the size of MDSO's TAM, as well as demand durability from small... More

Celgene (CELG) Expands Technology Relatinoship with Medidata Solutions (MDSO)

February 10, 2016 6:33 AM EST

Medidata (Nasdaq: MDSO) announced that Celgene Corporation (Nasdaq: CELG) has expanded its eight-year technology relationship with Medidata to add the... More